FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

838467004: Ubrogepant (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3897066010 Ubrogepant (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3897067018 Ubrogepant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3897066010 Ubrogepant (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3897067018 Ubrogepant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ubrogepant (substance) Is a Heterocyclic compound (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Ubrogepant (substance) Has disposition Calcitonin gene-related peptide receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Ubrogepant (substance) Is a Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Ubrogepant only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ubrogepant (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ubrogepant-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ubrogepant (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing ubrogepant (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ubrogepant (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Ubrogepant only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ubrogepant (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start